Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr;83(4):371-376.
doi: 10.1097/JCMA.0000000000000279.

Tumor lysis syndrome as a risk factor for very early mortality in HIV-associated non-Hodgkin's lymphoma: A 10-year single-center experience

Affiliations

Tumor lysis syndrome as a risk factor for very early mortality in HIV-associated non-Hodgkin's lymphoma: A 10-year single-center experience

Yea-Yuan Chang et al. J Chin Med Assoc. 2020 Apr.

Abstract

Background: Despite the effectiveness of combination antiretroviral therapy, persons living with human immunodeficiency virus (PLWHIV) remain at a high risk of developing non-Hodgkin lymphoma (NHL). We aimed to analyze the demographics and outcomes of the HIV-associated NHLs.

Methods: Between 2005 and 2014, PLWHIV with NHLs were retrospectively enrolled at a tertiary referral center. Characteristics and survival were reviewed and analyzed.

Results: Twenty-two HIV-associated NHLs were identified, with a median follow-up of 14 months (range, 0.1-139.7), including eight diffuse large B-cell lymphomas (DLBCLs), eight primary central nervous system lymphomas (PCNSLs), and six Burkitt's lymphomas (BLs). Nine patients (40.9%) were diagnosed with NHLs and HIV infection concurrently. The prognosis of DLBCL patients tended to be better prognosis than that of BL and PCNSL patients (median overall survival: not reached vs. 3.5 months, p = 0.056). Very early mortality (death within 14 days after NHL diagnosis) was noted in five patients (22.7%), and tumor lysis syndrome (TLS) is a predictive factor for very early mortality among PLWHIV (hazard ratio:11.3, 95% confidence interval: 1.1-114.4, p = 0.04).

Conclusion: Management of the early treatment phase of HIV-associated NHLs remains a major challenge. Careful intervention to patients with TLS might be the key to improve treatment outcomes.

PubMed Disclaimer

References

    1. Cingolani A, Cozzi Lepri A, Teofili L, Galli L, Mazzotta V, Baldin GM, et al.; ICONA Foundation Study groupSurvival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population.PLoS One201712e0186549
    1. Simard EP, Engels EA. Cancer as a cause of death among people with AIDS in the United States.Clin Infect Dis201051957–62
    1. Simard EP, Pfeiffer RM, Engels EA. Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States.Cancer20111171089–96
    1. Re A, Cattaneo C, Rossi G. Hiv and lymphoma: from epidemiology to clinical management.Mediterr J Hematol Infect Dis201911e2019004
    1. Yang CJ, Chen MY, Hsieh SM, Sheng WH, Sun HY, Hung CC, et al. Non-Hodgkin's lymphoma in patients with human immunodeficiency virus infection in Taiwan.J Microbiol Immunol Infect201043278–84

LinkOut - more resources